AbelsonTaylor – one of the world’s premier health and wellness advertising agencies – promoted Lynnette Hunter to executive vice president, director of client services, and Jeanine Koch to executive vice president, director of project management.
McCann Health announced Hilary Gentile’s promotion to the newly created position of Global Chief Strategy Officer.
CMI/Compas, media buying and planning for the nation’s top healthcare companies and part of WPP, announced the promotion of Gia Mauriello to EVP, Customer Experience and Excellence.
The Bloc, one of the largest independent health creative agencies, announced the promotion of Jennifer Matthews to CEO and president. Founding partners Susan Miller Viray and Rico Viray assume the respective positions of chairman of The Bloc and chairman of the global network The BlocPartners.
One is going, one is staying – and getting a promotion.
CMI/Compas, media buying and planning for the nation’s top healthcare companies and part of WPP (NYSE:WPP), announces the promotion of Dr. Susan Dorfman to President, CMI. Dorfman was most recently Chief Commercial Officer for CMI/Compas. As President, she is responsible for the growth and future direction of CMI Media, with a strategic focus on integrated […]
Tokyo-based Astellas Pharma announced that the company’s roxadustat met the primary endpoints in the Phase III ALPS clinical trial in chronic kidney disease patients with anemia not on dialysis.
WPP announced the appointment of Mark Read as Chief Executive Officer and his appointment to the Board of WPP as an Executive Director with immediate effect.
Ogilvy CommonHealth Worldwide announced the promotions of Raymond Johnson, Laura Kohler, and Beth Lebowitz all from VP, management supervisors, to SVP, management supervisors, within the organization’s NJ-based market access team.
Gilead Sciences Inc. announced that Gregg Alton was appointed Chief Patient Officer, a newly created role that will facilitate access to the company’s medicines and increase focus on reaching patients. The company also announced that Diana Brainard, MD, was promoted to Senior Vice President, HIV and Emerging Viral Infections, and that Andrew Cheng, MD, PhD, Chief Medical Officer, decided to leave Gilead to pursue another opportunity.